Medizinische Universität Graz - Research portal

Navigation/Search

Pilz, S; Theiler-Schwetz, V; Pandis, M; Trummer, C.
Endocrine Hypertension
J HYPERTON. 2019; 23(1): 25-34.
Web of Science

Leading authors Med Uni Graz: Pilz Stefan
Co-authors Med Uni Graz: Pandis Marlene; Theiler-Schwetz Verena; Trummer Christian
Altmetrics:
Abstract:: Endocrine hypertension is the most frequent cause of secondary hypertension affecting approximately 5 to 15% of hypertensive patients. Early diagnosis and therapy of endocrine forms of hypertension can partially or totally cure arterial hypertension thus translating into significantly reduced morbidity and mortality. Primary aldosteronism (PA) is by far the most common endocrine form of hypertension with a prevalence of about 5 to 10% in hypertensive patients. In general, diagnostics for endocrine hypertension should only be performed in case of a high clinical suspicion, but for PA a wide screening in about every second hypertensive patients (in particular in resistant hypertension) is recommended. The barrier to diagnostic procedures for pheochromocytoma/paraganglioma should also be low. Although endocrine forms of hypertension are very common, many affected patients are not or too late diagnosed and treated, and it is estimated that over 90% of PA cases remain unrecognized. Therefore, actions are required to close this diagnostic and treatment gap in order to improve the outcome of patients with arterial hypertension.
Find related publications in this database (Keywords): secondary hypertension; primary hyperaldosteronism; pheochromocytoma; diagnostics; therapy